BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 35060430)

  • 1. The influence of radiation dose on taste impairment in a prospective observational study cohort of oropharyngeal cancer patients.
    Stieb S; Engeseth GM; Mohamed ASR; He R; Perez-Martinez I; Rock S; Deshpande TS; Garden AS; Rosenthal DI; Frank SJ; Gunn GB; Fuller CD
    Acta Oncol; 2022 Feb; 61(2):146-152. PubMed ID: 35060430
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of radiation dose on patient-reported acute taste alteration in a prospective observational study cohort in head and neck squamous cell cancer (HNSCC).
    Morelli I; Desideri I; Romei A; Scoccimarro E; Caini S; Salvestrini V; Becherini C; Livi L; Bonomo P
    Radiol Med; 2023 Dec; 128(12):1571-1579. PubMed ID: 37642816
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The impact of tongue-deviating and tongue-depressing oral stents on long-term radiation-associated symptoms in oropharyngeal cancer survivors.
    Stieb S; Perez-Martinez I; Mohamed ASR; Rock S; Bajaj N; Deshpande TS; Zaid M; Garden AS; Goepfert RP; Cardoso R; Ferrarotto R; Reddy JP; Phan J; Morrison WH; Rosenthal DI; Koay EJ; Frank SJ; Fuller CD; Gunn GB;
    Clin Transl Radiat Oncol; 2020 Sep; 24():71-78. PubMed ID: 32642562
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term patient reported outcomes following radiation therapy for oropharyngeal cancer: cross-sectional assessment of a prospective symptom survey in patients ≥65 years old.
    ; Eraj SA; Jomaa MK; Rock CD; Mohamed ASR; Smith BD; Smith JB; Browne T; Cooksey LC; Williams B; Temple B; Preston KE; Aymard JM; Gross ND; Weber RS; Hessel AC; Ferrarotto R; Phan J; Sturgis EM; Hanna EY; Frank SJ; Morrison WH; Goepfert RP; Lai SY; Rosenthal DI; Mendoza TR; Cleeland CS; Hutcheson KA; Fuller CD; Garden AS; Gunn GB
    Radiat Oncol; 2017 Sep; 12(1):150. PubMed ID: 28888224
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intensity Modulated Proton Therapy Versus Intensity Modulated Photon Radiation Therapy for Oropharyngeal Cancer: First Comparative Results of Patient-Reported Outcomes.
    Sio TT; Lin HK; Shi Q; Gunn GB; Cleeland CS; Lee JJ; Hernandez M; Blanchard P; Thaker NG; Phan J; Rosenthal DI; Garden AS; Morrison WH; Fuller CD; Mendoza TR; Mohan R; Wang XS; Frank SJ
    Int J Radiat Oncol Biol Phys; 2016 Jul; 95(4):1107-14. PubMed ID: 27354125
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prospective observational evaluation of radiation-induced late taste impairment kinetics in oropharyngeal cancer patients: Potential for improvement over time?
    Stieb S; Mohamed ASR; Deshpande TS; Harp J; Greiner B; Garden AS; Goepfert RP; Cardoso R; Ferrarotto R; Phan J; Reddy JP; Morrison WH; Rosenthal DI; Frank SJ; Fuller CD; Brandon Gunn G;
    Clin Transl Radiat Oncol; 2020 May; 22():98-105. PubMed ID: 32373720
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development and validation of a contouring guideline for the taste bud bearing tongue mucosa.
    Stieb S; Mohamed ASR; He R; Zhu LL; McDonald BA; Wahid K; van Dijk LV; Ventura J; Ahmed S; McCoy L; Deshpande TS; Grant S; Reddy JP; Phan J; Garden AS; Rosenthal DI; Frank SJ; Gunn GB; Fuller CD
    Radiother Oncol; 2021 Apr; 157():63-69. PubMed ID: 33217499
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sparing bilateral neck level IB in oropharyngeal carcinoma and xerostomia outcomes.
    Tam M; Riaz N; Kannarunimit D; Peña AP; Schupak KD; Gelblum DY; Wolden SL; Rao S; Lee NY
    Am J Clin Oncol; 2015 Aug; 38(4):343-7. PubMed ID: 26208401
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Radiation-induced volume changes in parotid and submandibular glands in patients with head and neck cancer receiving postoperative radiotherapy: a longitudinal study.
    Wang ZH; Yan C; Zhang ZY; Zhang CP; Hu HS; Kirwan J; Mendenhall WM
    Laryngoscope; 2009 Oct; 119(10):1966-74. PubMed ID: 19688858
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Symptom Burden Associated With Late Lower Cranial Neuropathy in Long-term Oropharyngeal Cancer Survivors.
    Aggarwal P; Zaveri JS; Goepfert RP; Shi Q; Du XL; Swartz M; Gunn GB; Lai SY; Fuller CD; Hanna EY; Rosenthal DI; Lewin JS; Piller LB; Hutcheson KA
    JAMA Otolaryngol Head Neck Surg; 2018 Nov; 144(11):1066-1076. PubMed ID: 30193299
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A prospective study of salivary function sparing in patients with head-and-neck cancers receiving intensity-modulated or three-dimensional radiation therapy: initial results.
    Chao KS; Deasy JO; Markman J; Haynie J; Perez CA; Purdy JA; Low DA
    Int J Radiat Oncol Biol Phys; 2001 Mar; 49(4):907-16. PubMed ID: 11240231
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association of Risk Factors With Patient-Reported Voice and Speech Symptoms Among Long-term Survivors of Oropharyngeal Cancer.
    Aggarwal P; Hutcheson KA; Garden AS; Mott FE; Goepfert RP; Duvall A; Fuller CD; Lai SY; Gunn GB; Sturgis EM; Hanna EY; Shete S
    JAMA Otolaryngol Head Neck Surg; 2021 Jul; 147(7):615-623. PubMed ID: 33956062
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A phase II study to assess the efficacy of amifostine for submandibular/sublingual salivary sparing during the treatment of head and neck cancer with intensity modulated radiation therapy for parotid salivary sparing.
    Rosenthal DI; Chambers MS; Weber RS; Eisbruch A
    Semin Oncol; 2004 Dec; 31(6 Suppl 18):25-8. PubMed ID: 15726519
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Modeling of salivary production recovery after radiotherapy using mixed models: determination of optimal dose constraint for IMRT planning and construction of convenient tools to predict salivary function.
    Ortholan C; Chamorey E; Benezery K; Thariat J; Dassonville O; Poissonnet G; Bozec A; Follana P; Peyrade F; Sudaka A; Gerard JP; Bensadoun RJ
    Int J Radiat Oncol Biol Phys; 2009 Jan; 73(1):178-86. PubMed ID: 18565687
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intensity-modulated radiation therapy in head and neck cancers: The Mallinckrodt experience.
    Chao KS; Low DA; Perez CA; Purdy JA
    Int J Cancer; 2000 Apr; 90(2):92-103. PubMed ID: 10814959
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dosimetric advantages of intensity-modulated proton therapy for oropharyngeal cancer compared with intensity-modulated radiation: A case-matched control analysis.
    Holliday EB; Kocak-Uzel E; Feng L; Thaker NG; Blanchard P; Rosenthal DI; Gunn GB; Garden AS; Frank SJ
    Med Dosim; 2016; 41(3):189-94. PubMed ID: 27158021
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recurrences near base of skull after IMRT for head-and-neck cancer: implications for target delineation in high neck and for parotid gland sparing.
    Eisbruch A; Marsh LH; Dawson LA; Bradford CR; Teknos TN; Chepeha DB; Worden FP; Urba S; Lin A; Schipper MJ; Wolf GT
    Int J Radiat Oncol Biol Phys; 2004 May; 59(1):28-42. PubMed ID: 15093896
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical Use of A Priori Knowledge of Organ-At-Risk Sparing During Radiation Therapy Treatment for Oropharyngeal Cancer: Dosimetric and Patient Reported Outcome Improvements.
    Fried DV; Das SK; Marks LB; Chera BS
    Pract Radiat Oncol; 2022; 12(3):e193-e200. PubMed ID: 34958985
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Investigations on parotid gland recovery after IMRT in head and neck tumor patients.
    Stock M; Dörr W; Stromberger C; Mock U; Koizar S; Pötter R; Georg D
    Strahlenther Onkol; 2010 Dec; 186(12):665-71. PubMed ID: 21136030
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intensity modulated radiation therapy for oropharyngeal and oral cavity tumors: clinical use and experience.
    Claus F; Duthoy W; Boterberg T; De Gersem W; Huys J; Vermeersch H; De Neve W
    Oral Oncol; 2002 Sep; 38(6):597-604. PubMed ID: 12167438
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.